DZ1895A1 - Nouveaux dérivés alcanes 1,1-bis (hétéroazolyl) etleur utilisation comme agents neuro-inhibiteurs. - Google Patents

Nouveaux dérivés alcanes 1,1-bis (hétéroazolyl) etleur utilisation comme agents neuro-inhibiteurs.

Info

Publication number
DZ1895A1
DZ1895A1 DZ950069A DZ950069A DZ1895A1 DZ 1895 A1 DZ1895 A1 DZ 1895A1 DZ 950069 A DZ950069 A DZ 950069A DZ 950069 A DZ950069 A DZ 950069A DZ 1895 A1 DZ1895 A1 DZ 1895A1
Authority
DZ
Algeria
Prior art keywords
heteroazolyl
neuro
bis
new
inhibitory agents
Prior art date
Application number
DZ950069A
Other languages
English (en)
Inventor
Bernard Robin Boar
Duncan Alastair Gray
Dennis Mark O'shea
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of DZ1895A1 publication Critical patent/DZ1895A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DZ950069A 1994-06-07 1995-07-03 Nouveaux dérivés alcanes 1,1-bis (hétéroazolyl) etleur utilisation comme agents neuro-inhibiteurs. DZ1895A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9401965A SE9401965D0 (sv) 1994-06-07 1994-06-07 New compounds

Publications (1)

Publication Number Publication Date
DZ1895A1 true DZ1895A1 (fr) 2002-02-17

Family

ID=20394274

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ950069A DZ1895A1 (fr) 1994-06-07 1995-07-03 Nouveaux dérivés alcanes 1,1-bis (hétéroazolyl) etleur utilisation comme agents neuro-inhibiteurs.

Country Status (26)

Country Link
US (2) US5843971A (fr)
EP (1) EP0765325A1 (fr)
JP (1) JPH10503172A (fr)
CN (1) CN1051546C (fr)
AU (1) AU691303B2 (fr)
BR (1) BR9507923A (fr)
CA (1) CA2190128A1 (fr)
CZ (1) CZ357796A3 (fr)
DZ (1) DZ1895A1 (fr)
EE (1) EE9600197A (fr)
FI (1) FI964879A0 (fr)
HR (1) HRP950302A2 (fr)
HU (1) HUT76050A (fr)
IL (1) IL113773A (fr)
IS (1) IS4383A (fr)
MA (1) MA23574A1 (fr)
NO (1) NO307421B1 (fr)
NZ (1) NZ287973A (fr)
PL (1) PL318470A1 (fr)
RU (1) RU2155763C2 (fr)
SE (1) SE9401965D0 (fr)
SK (1) SK155696A3 (fr)
TN (1) TNSN95065A1 (fr)
WO (1) WO1995033747A1 (fr)
YU (1) YU38695A (fr)
ZA (1) ZA954145B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9401965D0 (sv) * 1994-06-07 1994-06-07 Astra Ab New compounds
US6921538B2 (en) * 2002-05-10 2005-07-26 Allergan, Inc. Therapeutic treatments for neuropsychiatric disorders
US7649098B2 (en) * 2006-02-24 2010-01-19 Lexicon Pharmaceuticals, Inc. Imidazole-based compounds, compositions comprising them and methods of their use
TW200920355A (en) * 2007-09-06 2009-05-16 Lexicon Pharmaceuticals Inc Compositions and methods for treating immunological and inflammatory diseases and disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2801794A1 (de) * 1978-01-17 1979-07-19 Basf Ag Verfahren zur herstellung von thiazolderivaten und neue thiazole
US5554620A (en) * 1993-09-14 1996-09-10 Sterling Winthrop Inc. Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof
SE9401965D0 (sv) * 1994-06-07 1994-06-07 Astra Ab New compounds

Also Published As

Publication number Publication date
PL318470A1 (en) 1997-06-23
CZ357796A3 (en) 1997-06-11
TNSN95065A1 (fr) 1996-02-06
RU2155763C2 (ru) 2000-09-10
SE9401965D0 (sv) 1994-06-07
NO965182D0 (no) 1996-12-04
IL113773A0 (en) 1995-08-31
FI964879A (fi) 1996-12-05
CN1150426A (zh) 1997-05-21
NZ287973A (en) 1998-04-27
JPH10503172A (ja) 1998-03-24
YU38695A (sh) 1998-12-23
EP0765325A1 (fr) 1997-04-02
AU2685995A (en) 1996-01-04
MA23574A1 (fr) 1995-12-31
EE9600197A (et) 1997-06-16
US5843971A (en) 1998-12-01
NO965182L (no) 1996-12-04
BR9507923A (pt) 1997-09-23
HUT76050A (en) 1997-06-30
ZA954145B (en) 1995-12-07
AU691303B2 (en) 1998-05-14
CN1051546C (zh) 2000-04-19
US5665747A (en) 1997-09-09
IS4383A (is) 1996-11-12
IL113773A (en) 2000-02-29
CA2190128A1 (fr) 1995-12-14
NO307421B1 (no) 2000-04-03
FI964879A0 (fi) 1996-12-05
SK155696A3 (en) 1997-05-07
HU9603386D0 (en) 1997-01-28
HRP950302A2 (en) 1997-08-31
WO1995033747A1 (fr) 1995-12-14

Similar Documents

Publication Publication Date Title
NO990544L (no) Substituerte pyrido- eller pyrimido-inneholdende 6,6 eller 6,7-bycykliske derivater
IS4963A (is) Setnar 6,5-heteró-bísýklískar afleiður
ID19770A (id) Feniketoenil 2-dan 2,5-disubstitusi
DE671419T1 (de) Herstellung von Polybutenen.
TR27961A (tr) Sübstitüe edilmis 1,2,3,4 -tetrahidro-5-nitro-pirimidinler.
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
FI970438A0 (fi) Foerfarande i panna, saerskilt i sodapanna
IT1302243B1 (it) Sintesi dell'1,1,1,3,3-pentafluoropropano.
DE59609043D1 (de) Feste Lösungen von 1,4-Diketopyrrolopyrrolen
DE59912915D1 (de) Herstellung von 4,4'-Diketo-carotinoiden
DZ1895A1 (fr) Nouveaux dérivés alcanes 1,1-bis (hétéroazolyl) etleur utilisation comme agents neuro-inhibiteurs.
DE69828906D1 (de) Herstellung von 1,3 propandiolestern
TR199501336A2 (tr) Talim tertibati.
IT1278010B1 (it) Ftalocianine d'alluminio, loro preparazione e loro impiego come coloranti.
DE69702961T2 (de) Herstellung von 1,1-difluorethan
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
DE69611546D1 (de) Herstellung von 2,6-dimethylnaphthalin
TR199700219A3 (tr) 1,25-Dihidroksi-16, 22, 23-Trisdihidro-kolkalsiferol türevleri.
FR2727965B1 (fr) 4,4'-(phenylenediisopropyl )-bis- (2.6-dialkylphenylisocyanates)
DE59709923D1 (de) 2- und 2,5-substituierte phenylketoenole
IT1277138B1 (it) Composti tetrakisazoici, loro preparazione e loro impiego come coloranti.
FR2719596B1 (fr) Nouveaux composés disazoïques, leur préparation et leur utilisation comme colorants.
TR199500975A2 (tr) Cok konsantre ve stoklanmaya dayanikli sekilde olan, inceltilebilir alüminyum triformiat'li dabaklama maddeleri ve bunlarin kullanilmasi.
DZ1893A1 (fr) Nouveaux médicaments contenant des composés de 3,7-diazabiycloÄ3,3,1Ü-nonane.
ES1026810Y (es) Camilla hidraulica, perfeccionada.